Skip to main content
construction release_alert
The Scholars Team is working with OIT to resolve some issues with the Scholars search index
cancel

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

Publication ,  Journal Article
Ettinger, DS; Wood, DE; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; D'Amico, TA; Dilling, TJ; Dowell, J ...
Published in: J Natl Compr Canc Netw
March 2, 2021

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2, 2021

Volume

19

Issue

3

Start / End Page

254 / 266

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Immunotherapy
  • Humans
  • Carcinoma, Non-Small-Cell Lung
  • Biomarkers, Tumor
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., … Hughes, M. (2021). NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw, 19(3), 254–266. https://doi.org/10.6004/jnccn.2021.0013
Ettinger, David S., Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.J Natl Compr Canc Netw 19, no. 3 (March 2, 2021): 254–66. https://doi.org/10.6004/jnccn.2021.0013.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021 Mar 2;19(3):254–66.
Ettinger, David S., et al. “NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.J Natl Compr Canc Netw, vol. 19, no. 3, Mar. 2021, pp. 254–66. Pubmed, doi:10.6004/jnccn.2021.0013.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, Dilling TJ, Dowell J, Gettinger S, Gubens MA, Hegde A, Hennon M, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW, Lovly CM, Martins RG, Massarelli E, Morgensztern D, Ng T, Otterson GA, Patel SP, Riely GJ, Schild SE, Shapiro TA, Singh AP, Stevenson J, Tam A, Yanagawa J, Yang SC, Gregory KM, Hughes M. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021. J Natl Compr Canc Netw. 2021 Mar 2;19(3):254–266.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2, 2021

Volume

19

Issue

3

Start / End Page

254 / 266

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Immunotherapy
  • Humans
  • Carcinoma, Non-Small-Cell Lung
  • Biomarkers, Tumor
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis